20-51790353-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_020436.5(SALL4):c.2130G>A(p.Thr710Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00308 in 1,614,048 control chromosomes in the GnomAD database, including 148 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.016 ( 84 hom., cov: 32)
Exomes 𝑓: 0.0017 ( 64 hom. )
Consequence
SALL4
NM_020436.5 synonymous
NM_020436.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.69
Publications
2 publications found
Genes affected
SALL4 (HGNC:15924): (spalt like transcription factor 4) This gene encodes a zinc finger transcription factor thought to play a role in the development of abducens motor neurons. Defects in this gene are a cause of Duane-radial ray syndrome (DRRS). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2015]
SALL4 Gene-Disease associations (from GenCC):
- Duane-radial ray syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia
- Duane retraction syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- IVIC syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 20-51790353-C-T is Benign according to our data. Variant chr20-51790353-C-T is described in ClinVar as Benign. ClinVar VariationId is 338772.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0553 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SALL4 | NM_020436.5 | c.2130G>A | p.Thr710Thr | synonymous_variant | Exon 2 of 4 | ENST00000217086.9 | NP_065169.1 | |
| SALL4 | XM_047440318.1 | c.1824G>A | p.Thr608Thr | synonymous_variant | Exon 2 of 4 | XP_047296274.1 | ||
| SALL4 | NM_001318031.2 | c.1150+980G>A | intron_variant | Intron 2 of 3 | NP_001304960.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SALL4 | ENST00000217086.9 | c.2130G>A | p.Thr710Thr | synonymous_variant | Exon 2 of 4 | 1 | NM_020436.5 | ENSP00000217086.4 | ||
| SALL4 | ENST00000395997.3 | c.1150+980G>A | intron_variant | Intron 2 of 3 | 1 | ENSP00000379319.3 | ||||
| SALL4 | ENST00000371539.7 | c.131-1212G>A | intron_variant | Intron 1 of 2 | 1 | ENSP00000360594.3 |
Frequencies
GnomAD3 genomes AF: 0.0163 AC: 2484AN: 152080Hom.: 83 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
2484
AN:
152080
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00424 AC: 1066AN: 251230 AF XY: 0.00324 show subpopulations
GnomAD2 exomes
AF:
AC:
1066
AN:
251230
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00170 AC: 2482AN: 1461850Hom.: 64 Cov.: 31 AF XY: 0.00151 AC XY: 1099AN XY: 727228 show subpopulations
GnomAD4 exome
AF:
AC:
2482
AN:
1461850
Hom.:
Cov.:
31
AF XY:
AC XY:
1099
AN XY:
727228
show subpopulations
African (AFR)
AF:
AC:
1916
AN:
33478
American (AMR)
AF:
AC:
143
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26136
East Asian (EAS)
AF:
AC:
0
AN:
39700
South Asian (SAS)
AF:
AC:
6
AN:
86258
European-Finnish (FIN)
AF:
AC:
1
AN:
53378
Middle Eastern (MID)
AF:
AC:
11
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
155
AN:
1112012
Other (OTH)
AF:
AC:
250
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
175
350
525
700
875
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0164 AC: 2491AN: 152198Hom.: 84 Cov.: 32 AF XY: 0.0161 AC XY: 1200AN XY: 74404 show subpopulations
GnomAD4 genome
AF:
AC:
2491
AN:
152198
Hom.:
Cov.:
32
AF XY:
AC XY:
1200
AN XY:
74404
show subpopulations
African (AFR)
AF:
AC:
2376
AN:
41530
American (AMR)
AF:
AC:
79
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5168
South Asian (SAS)
AF:
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
AC:
0
AN:
10604
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
15
AN:
68006
Other (OTH)
AF:
AC:
20
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
124
249
373
498
622
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
17
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Duane-radial ray syndrome Benign:1
Jan 22, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Oculootoradial syndrome;C1623209:Duane-radial ray syndrome Benign:1
Jul 18, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.